Storage and handling
Store at controlled room temperature between 20°C-25°C (68°F-77°F) and protect from light. Avoid excessive heat (104°F).
Store at controlled room temperature between 20°C-25°C (68°F-77°F) and protect from light. Avoid excessive heat (104°F).
nfz™ puffer
NDC: 59051-2674-0
NADA 011-154, Approved by FDA
Contains 0.2% Nitrofurazone in a water-soluble base
Carcinogenesis: Nitrofurazone has been shown to produce mammary tumors in rats and ovarian tumors in mice.
Some people may be hypersensitive to this product. Either wear gloves when applying, or wash hands afterwards.
Keep out of Reach of Children
CAUTION: Federal Law prohibits the use of this product in food producing animals.
FOR EYE INFECTIONS IN DOGS AND CATS- remove cap and squeeze container to force a stream of powder directly into the eye. Repeat treatment daily. If there is no improvement after 4 days a new diagnosis should be made or a veterinarian consulted.
FOR EAR INFECTIONS IN DOGS AND CATS - clean out inside of ear and ear canal with cotton pledget. Prepared cotton swabs which may be obtained at any drug store are best for cleaning out the ear canal. Insert nozzle of container into ear canal and squeeze twice. Repeat daily until improvement is noted.
FOR SURFACE WOUNDS, CUTS AND ABRASIONS - Apply daily until danger from infection is eliminated or until healing takes place.
Store at controlled room temperature between 20°C-25°C (68°F-77°F) and protect from light. Avoid excessive heat (104°F).
LOT NO./EXP. DATE: SEE BOTTOM OF CONTAINER
Manufactured by:
Neogen Corporation
Lexington, KY 40511
859-254-1221
Made in the USA
Item No. 142674
L748-0618
SHAKE OR ROTATE TO LOOSEN POWDER
Restricted Drug- (California)
Use only as Directed
nfz™ puffer
NDC: 59051-2674-0
NADA 011-154, Approved by FDA
NET WT
1.59 oz (45 g)
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59051-2674 | 59051-2674-0 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| NITROFURAZONE | X8XI70B5Z6 | ACTIB |
Adverse event summaries are temporarily unavailable. Other product information remains available.